Cargando…

Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range?

The number of clinical trials using mesenchymal stem cells (MSCs) has increased since 2008, but this trend slowed in the past several years and dropped precipitously in 2018. Previous reports have analyzed MSC clinical trials by disease, phase, cell source, country of origin, and trial initiation da...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabat, Maciej, Bobkov, Ivan, Kumar, Suneel, Grumet, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954709/
https://www.ncbi.nlm.nih.gov/pubmed/31804767
http://dx.doi.org/10.1002/sctm.19-0202